2. Academic Wits University Research Outputs (All submissions)

Permanent URI for this community

https://hdl.handle.net/10539/36826

Browse

Browsing 2. Academic Wits University Research Outputs (All submissions) by SDG "SDG-3: Good health and well-being"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Genomewide association study metaanalysis of blood pressure traits and hypertension in subSaharan African populations an AWIGen study
    (Nature Research) Norris, Shane A.; Choudhury, Ananyo; Hazelhurst, Scott ; Crowther, Nigel ; Boua, Palwende ; Sorgho, Hermann; Agongo, Godfred; Nonterah, Engelbert A.; Micklesfield, Lisa K.; Singh, Surina; Kisiangani, Isaac; Mohamed, Shukri; Gomez-Olive, Francesc X.; Tollman, Stephen M.; Choma, Solomon; Brandenburg, J-T.; Ramsay, Michele
  • Thumbnail Image
    Item
    HIV1 resupression on a firstline regimen despite the prescence of phenotypic drug resistance
    (Public Library of Science) Adriaan Basson; Salome Charalambous; Christopher Hoffmann; Lynn Morris
    We have previously reported on HIV-1 infected patients who fail anti-retroviral therapy but manage to re-suppress without a regimen change despite harbouring major drug resistance mutations. Here we explore phenotypic drug resistance in such patients in order to better understand this phenomenon. Patients (n = 71) failing a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen, but who subsequently re-suppressed on the same regimen, were assessed for HIV-1 genotypic drug resistance through Sanger sequencing. A subset (n =23) of these samples, as well as genotypically matched samples from patients who did not re-suppress (n = 19), were further assessed for phenotypic drug resistance in an in vitro single cycle assay. Half of the patients (n = 36/71, 51%) harboured genotypic drug resistance, with M184V(n=18/36,50%)andK103N(n=16/36,44%)being the most prevalent mutations. No significant difference in the median time to re-suppression (31–39 weeks) were observed for either group (p = 0.41). However, re-suppressors with mutant virus rebounded significantly earlier than those with wild-type virus (16 vs. 33 weeks; p = 0.014). Similar phenotypic drug resistance profiles were observed between patients who re-suppressed and patients who failed to re-suppress. While most remained susceptible to stavudine (d4T) and zidovudine (AZT), both groups showed a reduced susceptibility to 3TC and NNRTIs. HIV- 1 infected patients on an NNRTI-based regimen can achieve viral re-suppression on the same regimen despite harbouring viruses with genotypic and phenotypic drug resistance. However, re-suppression was less durable in those with resistance, reinforcing the importance of appropriate regimen choices, ongoing viral load monitoring and adherence counselling.
  • Thumbnail Image
    Item
    Locked down impact of covid 19 restrictions on trauma presentations to the emergency department
    Venter, Anica; Lewis, Carolyn; Saffy, Patricia; Chadinha, Louis
    Background: COVID-19 was recognised as a global pandemic on 11 March 2020. In South Africa (SA), a nationwide lockdown was implemented at midnight on 26 March to prepare for the predicted surge and slow the spread of the virus. Objectives: To compare the volume and type of presentations of trauma secondary to interpersonal violence and road traffic collisions (RTCs) during two 5-month periods, from February to June 2019 and 2020, in the emergency department (ED) of an academic tertiary hospital in Gauteng Province, SA. In 2020, February - June included the lockdown period. Methods: An observational retrospective audit of the patient register at the Helen Joseph Hospital ED was conducted, comparing the number of trauma presentations secondary to interpersonal violence (assaults with gunshot wounds, general assaults including mob assaults, assaults with stab wounds) and RTC presentations between February and June 2019 and 2020. Results: A total of 4 300 trauma presentations secondary to interpersonal violence and RTCs were noted in the 5-month period February - June 2019, as opposed to 3 239 presentations in February - June 2020 (25% decline). A 40% decline in the number of RTCs, from 1 704 in February - June 2019 to 1 026 in the corresponding period for 2020, was noted and found to be statistically significant (p=0.03). Declines in the volume of trauma cases secondary to interpersonal violence and of overall trauma cases were only directional in favour of 2020, but not statistically significant. Conclusions: The volume of trauma presentations secondary to interpersonal violence and RTCs in the Helen Joseph Hospital ED decreased during the lockdown period. The decline in the volume of RTCs was statistically significant, but declines in the volume of trauma presentations secondary to interpersonal violence and in the volume of overall trauma presentations were not.
  • Thumbnail Image
    Item
    Overview of the Haematological effects of COVID19 infection
    Wiggill, Tracey M.; Mayne, Elizabeth S.; Vaughan, Jenifer L.; Louw, Susan
    From its early origins, COVID-19 has spread extensively and was declared a global pandemic by the World Health Organization in March of 2020. Although initially thought to be predominantly a respiratory infection, more recent evidence points to a multisystem systemic disease which is associated with numerous haematological and immunological disturbances in addition to its other effects. Here we review the current knowledge on the haematological effects of COVID-19.
  • Thumbnail Image
    Item
    The Novel Coronavirus and Haemostatic abnormalities pathophysiology clinical manifesttations and treatment recommendations
    Susan Louw; Barry Jacobson; Elizabeth Mayne; Tracey Wiggill
    The COVID-19 pandemic, caused by the SARS-C0V-2 virus, was initially considered and managed in a similar manner to the previous SARS epidemic as they are both caused by coronaviruses. What has now become apparent is that a major cause of morbidity and mortality in COVID-19 is abnormal thrombosis. This thrombosis occurs on a macro- and microvascular level and is unique to this disease. The virus has been demonstrated in the endothelium of the pulmonary alveoli and as such is thought to contribute to the devastating respiratory complications encountered. D-dimer concentrations are frequently raised in COVID to levels not frequently seen previously. The optimal anticoagulation treatment in COVID remains to be determined, and the myriad of pathophysiologic effects caused by this virus in the human host have also yet to be fully elucidated.
All items in this collection are protected by copyright. Please respect the copyright regulations as indicated and acknowledge the copyright owner according to accepted standards and norms.